Navigation Links
Uroplasty to Present at ROTH Capital Partners 20th Annual OC Growth Stock Conference
Date:2/6/2008

MINNEAPOLIS, Feb. 6 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (Amex: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunction, announced today that it will be presenting at the ROTH Capital Partners OC Growth Conference on Wednesday, February 20, 2008 at the Ritz Carlton Laguna Nigel. David Kaysen, Uroplasty's President and CEO and Medi Jiwani, Uroplasty's Vice President and CFO, will present the Company's business strategy and financial results at 4:00 p.m. Pacific Time.

Attendance at the conference is by invitation only. A live audio-only webcast of the presentation will be broadcast via the Internet. Those interested in listening to the webcast may access it at Uroplasty's website at http://www.uroplasty.com. An archived replay of the presentation will also be available shortly after the live presentation at Uroplasty's website.

Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly-owned subsidiaries in The Netherlands and the United Kingdom, is a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions. Our primary focus is the commercialization of our Urgent PC(R) system, which we believe is the only FDA-approved non-surgical neurostimulation therapy for the treatment of overactive bladder symptoms (OAB). We also offer Macroplastique(R) Implants, a bulking agent for the treatment of urinary incontinence. Please visit Uroplasty, Inc. at http://www.uroplasty.com.


'/>"/>
SOURCE Uroplasty, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Uroplasty Expands Marketing Program for Urology Practices
2. Uroplasty, Inc. Announces Pricing of a Public Offering of Its Common Stock
3. Uroplasty, Inc. Reports Record Sales For Second Fiscal Quarter
4. Uroplasty to Host Second Quarter Conference Call on November 1
5. Uroplasty, Inc. Announces Filing of Registration Statement for Offering of Common Stock
6. HMS Holdings Corp. to Present at 2008 UBS Global Healthcare Services Conference
7. West Pharmaceutical Services to Present at the 2008 UBS Global Healthcare Services Conference
8. Sharps Compliance Corp. to Present at the RedChip Small-Cap Investor Conference in Scottsdale, Arizona
9. Vical to Present at BIO CEO and Investor Conference
10. ADVENTRX Pharmaceuticals to Present at The 10th Annual BIO CEO & Investor Conference
11. NPS Pharmaceuticals to Present at BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...A, S.C., Nov. 21 U.S. N...for Quality Assurance (NCQA) ranked BlueChoice(R) ...merica,s Best Health Plans(TM), published in U.S. ..., The respected annual ranking ranks the nation,...ber satisfaction and NCQA accreditation scores. NC...
(Date:11/21/2008)...N LAKES, N.J., Nov. 21 T...medical intervention in treating 88 percent of pat...t of Americans treated for a chronic condition acc...ing and 75 percent of all medical costs. A propri...s by Medco Health Solutions, Inc. (NYSE: MHS ) s...
(Date:11/21/2008)...ound 2 popular drugs do not cause genetic damage t... 21 (HealthDay News) -- Two popular medications fo...r (ADHD) do not cause genetic damage linked to an ...says. , The study, done by researchers at Duke ...tes of Health, counters a previous one that report...
(Date:11/21/2008)...0 B.C., a new and deadly diseaseits cause remains ...state was teeming with citizens, soldiers and refu...rta. As streets filled with corpses, social order ... returned twice and Athens lost a third of its pop... marked the beginning of the end of the Golden Age...
Breaking Medicine News(10 mins):Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6Health News:ADHD Medications Don't Pose Cancer Risk 2Health News:Study of ancient and modern plagues finds common features 2Health News:Study of ancient and modern plagues finds common features 3Health News:Study of ancient and modern plagues finds common features 4
...s have measurable anomalies in their immune system...idely believed that stress may impair health, alth...w researchers at Washington University in the US r... has a specific effect on immunity. When an infla...
... and infallible test for bowel cancer based upon a...now that bowel cancer is highly curable if caught ...exam// of the bowel can reduce the incidence of th... that a reliable test can also be done on samples ...
...ical and Research Center report in the New England...matitis, also known as eczema, are susceptible to ...fail to produce effective amounts of two antimicro...cal significance of these peptides in humans, and ...
...t was observed that the valve helps patients with ...tions. The main symptom of esophagal cancer is dif...s often well advanced by the time this symptom// b... generally poor and quite often all that can be do...
Other Medicine News:Health News:Eczema patients lack natural antibiotic in skin 2
(Date:11/20/2008)...e/ -- New Jersey American Water has lifted the pr... in the following municipalities in Middlesex, Som...nty , , , Dunellen , Edison ...uth Plainfield , , , , Somerset Cou...gewater , Green Brook , Hillsborough...
(Date:11/20/2008)...re-FirstCall/ -- Bionovo, Inc.,(Nasdaq: BNVI ) ...e Phase 1B,clinical trial of their lead drug cand...01, at the Society for Integrative Oncology,s Fift...The Company,s oral presentation was selected,as a...art of the Best of the,SIO Session on November 20...
(Date:11/20/2008)...wswire/ -- The Scandinavian-based drug,developmen... studies on its,lead antimicrobial candidate LTX-...udies showed that the novel lytic peptidomimetic h...ntly better towards killing Staphylococcus,aureus...ndard drugs. In,addition to this it has proven ef...
(Date:11/19/2008)...re/ -- Biotech scientists increasingly are applyin...better understand the effects of novel drug candid...ic Engineering & Biotechnology News ( GEN ). ...ew compound,s mechanism of action and eventually d...ding to the November 15 issue of GEN . ( http://w...
Breaking Medicine Technology:New Jersey American Water Lifts Precautionary Boil Water Advisory For Middlesex, Somerset and Union Counties 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2GEN Reports on the Trend Toward Predictive Toxicogenomics 2Viral recombination another way HIV fools the immune system 4135 1Viral recombination another way HIV fools the immune system 4135 2Researchers probe geographical ties to ALS cases among 1991 Gulf War veterans 24245 1Researchers probe geographical ties to ALS cases among 1991 Gulf War veterans 24245 2Researchers probe geographical ties to ALS cases among 1991 Gulf War veterans 24245 3A virtual toothache helps student dentists 24244 1A virtual toothache helps student dentists 24244 2A virtual toothache helps student dentists 24244 3Lung Cancer Trial Targets Asbestos Related Disease 24241 1Lung Cancer Trial Targets Asbestos Related Disease 24241 2
.... , AURORA, ON, March 30, 2007 /PRNewswire-FirstCa...its phase II clinical study of its,Topical Interfe...HPV) induced low-grade cervical lesions. , The stu...atment,in nearly half of the treated patients. In ...fety profile, with no significant local,intoleranc...
... of Working Age People with Diabetes, Hospital,and...nal Averages, PITTSBURGH, April 02, 2007 /PRNewswi...Health (PBGH) announced today the,release of a new...re for people with Type 2 diabetes. The inaugural ...s an overview of patient,demographics, hospital an...
Other Medicine Technology:Helix BioPharma Corp. Announces Positive Phase II Clinical Results,with its Topical Interferon Alpha-2b 2Helix BioPharma Corp. Announces Positive Phase II Clinical Results,with its Topical Interferon Alpha-2b 3Helix BioPharma Corp. Announces Positive Phase II Clinical Results,with its Topical Interferon Alpha-2b 4Helix BioPharma Corp. Announces Positive Phase II Clinical Results,with its Topical Interferon Alpha-2b 5Helix BioPharma Corp. Announces Positive Phase II Clinical Results,with its Topical Interferon Alpha-2b 6State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 2State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 3State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 4
The Chalam Mid Field lens can be used for air/gas exchange and has a bi-concave design to provide the widest field available in a direct image surgical lens. This lens was developed with K.V. Chalam,
...enses offer the high resolution, high magnificatio... simple two part design separates for easy cleanin... Simply autoclave, add saline or water to the cont...oClave Sterilizable Lenses The ACS Vitrectomy Lens...
With somewhat higher magnification and increased stereopsis, the Central Retinal is best suited for detailed visualization to the equatorial regions. The Central Retinal is ideal for vitrectomy in di
MiniQuad XL is recommended for evaluating vitreoretinal relationships of the entire fundus and in the management of dislocated lenses. It is the ideal lens for small pupil fundus viewing with the ope
Medicine Products: